Published in:
01-01-2016 | Original Paper
Health-related quality of life changes in patients undergoing repeated catheter ablation for atrial fibrillation
Published in: Clinical Research in Cardiology | Issue 1/2016
Login to get accessAbstract
Objective
Pulmonary vein isolation (PVI) for paroxysmal or non-paroxysmal atrial fibrillation (AF) should increase health-related quality of life (QOL).
Design
Retrospective cohort study of consecutive patients scheduled for PVI.
Setting
University Medical Center.
Main outcome measures
QOL was assessed using the physical (PCS) and mental (MCS) component summary scores from the SF-12v2 in patients undergoing PVI (mean 50, range 0–100, with higher scores indicating greater QOL). SF-12v2 was obtained at initial presentation (3-months) before PVI and after PVI at the end of follow-up (mean 1.7 ± 1.4 years) which included: (1) Clinical status, ECG, and 24-h ECG every 3 months, (2) trans-telephonic ECGs for 4 weeks every 3 months, or (3) continuous ECG via implanted devices. A recurrence was any atrial arrhythmia >30 s.
Results
Out of 229 patients (73 % males; 58 ± 11 years), 72 % returned SF-12v2 regarding 187 PVI procedures: 56 % for 1st PVI, 48 % for 2nd PVI, 71 % for 3rd PVI, and 44 % for 4th PVI. The mean difference between before and after PVI was 10 for PCS and 9 for MCS. History of paroxysmal or non-paroxysmal AF did not influence QOL (p = 0.724). Patients with an estimated PCS improvement ≥10 or an estimated MCS improvement ≥9 had the best outcome after repeated PVI. Success rates were 72 or 82 % after 1 year compared to 20 and 22 % in patients not achieving this improvement, respectively (p < 0.0001).
Conclusion
Improvement in QOL correlates with success of AF ablation after single and repeated PVI. Assessment of QOL pre- and post-PVI can complement ECG techniques for PVI success monitoring.